Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,428 hedge funds and large institutions have $81.5B invested in Celgene Corp in 2017 Q2 according to their latest regulatory filings, with 97 funds opening new positions, 632 increasing their positions, 482 reducing their positions, and 68 closing their positions.
43% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 68
31% more repeat investments, than reductions
Existing positions increased: 632 | Existing positions reduced: 482
19% more call options, than puts
Call options by funds: $1.4B | Put options by funds: $1.18B
6% more capital invested
Capital invested by funds: $76.7B → $81.5B (+$4.74B)
1% more funds holding
Funds holding: 1,417 → 1,428 (+11)
1% less funds holding in top 10
Funds holding in top 10: 129 → 128 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$1.01B |
| 2 |
BlackRock
New York
|
+$378M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$219M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$197M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$190M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$292M |
| 2 |
SHCM
Sachem Head Capital Management
New York
|
-$205M |
| 3 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
-$176M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$139M |
| 5 |
JP Morgan Chase
New York
|
-$122M |
CELG Hedge Fund Activity: Q2 2017 in Review
1,428 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q2 2017, worth a combined $81.5B — up 6.2% from $76.7B a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new CELG positions and 68 closed out — a net gain of 29 holders — while 632 added to existing stakes and 482 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $1.01B. The largest seller was T. Rowe Price Associates, cutting an estimated $292M.
- 1,428 institutional investors held Celgene Corp (CELG) as of Q2 2017, up from 1,417 in Q1 2017.
- Funds reported $81.5B of Celgene Corp stock for Q2 2017, up 6.2% quarter-over-quarter.
- 97 funds opened new Celgene Corp positions in Q2 2017 and 68 closed out, a net change of +29 holders.
- The largest Celgene Corp buyer in Q2 2017 was Janus Henderson Group, an estimated $1.01B added.
- The largest Celgene Corp seller in Q2 2017 was T. Rowe Price Associates, an estimated $292M sold.
Based on aggregated 13F filings for Q2 2017.